Doctoral Research Advisor and Thesis Committee Member @ (July 2021 - March 2023)
Director, Translational Science @ (February 2020 - March 2023)
Associate Director, Translational Science @ (April 2018 - March 2023)
Senior Research Scientist and Leader of Research Team for Andecaliximab (ADX, GS-5745, anti-MMP9) @ (December 2016 - April 2018)
Research Scientist II, Biologics and Target Biology @ (July 2011 - December 2016)
Research Scientist I @ (December 2007 - July 2011)
Fellow @ (September 2004 - August 2007)
Graduate Researcher @ UC Berkeley (January 2002 - January 2007)
Summer Associate @ (May 2000 - August 2000)
Fellow @ (June 1999 - August 1999)
Andy Greenstein Education
University of California, Berkeley
PhD (Biochemistry and Molecular Biology)
2002-2007
University of Connecticut
B.S. (Biochemistry)
Andy Greenstein Skills
Antibodies
Assay Development
Bioanalysis
Biochemistry
Biologics
Biomarker Discovery
Biotechnology
Cell Biology
Cross-functional Team Leadership
Drug Development
Drug Discovery
Drug Resistance
Enzymes
Extracellular Matrix
Fibrosis
High Throughput Screening
Immunogenicity
Infectious Diseases
Inflammation
Life Sciences
Lifesciences
Molecular Biology
Monoclonal Antibodies
Oncology
Project Management
Protein Chemistry
Protein Expression
Protein Purification
Research
Scientific Communications
Technology Transfer
Translational Research
Andy Greenstein Summary
Andy Greenstein, based in San Francisco, CA, US, is currently a Senior Director, Scientific Strategy at Exelixis. Andy Greenstein brings experience from previous roles at University of Brighton, Corcept Therapeutics and Gilead Sciences. Andy Greenstein holds a 2002 - 2007 PhD in Biochemistry and Molecular Biology @ University of California, Berkeley. With a robust skill set that includes Antibodies, Assay Development, Bioanalysis, Biochemistry, Biologics and more. Andy Greenstein has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Andy Greenstein?
Find contact details for 700 million professionals.